Global market for photoacoustic imaging was over USD 68 million and will grow at over 14% CAGR from 2023 to 2032, driven by growing incidence of chronic disorders globally.
Photoacoustic tomography imaging market size will reach USD 130 million in 2032, on account of growing investments in medical imaging technology.
North America photoacoustic imaging market size will be over USD 89 million by 2032, owing to increasing preference for non-invasive disease diagnosis for effective patient care in the region.
Some of the leading photoacoustic imaging industry contenders are Vibronix Inc, TomoWave Laboratories, Seno Medical Instruments, iThera Medical GmbH, Photo sound Technologies Inc, Endra Life Sciences, and Aspectus GmbH, among others.